By Scientia Professor Anthony D Kelleher

Conference Abstracts

Prankumar S; Boli R; Gare J; Schulz M; Pekon S; Scott G; Silim S; Keno H; Ripa P; Gideon N; Kombati Z; Boas P; Starr M; Vali G; Willie B; Vallely A; Pomat W; Kelleher A; Badman S; Kelly-Hanku A, 2023, 'The journey of blood: working with point-of care technologies for HIV viral load testing and infant diagnosis in Papua New Guinea', in The journey of blood: working with point-of care technologies for HIV viral load testing and infant diagnosis in Papua New Guinea, Brisbane, presented at International AIDS Society Conference on HIV Science, Brisbane, 23 July 2023 - 26 July 2024

Gare J; Schulz M; Pekon S; Silim S; Keno H; Willie B; Boas P; Ripa P; Kombati Z; Gideon N; Pomat W; Kelleher A; Vallely A; Scott G; Obeng B; Starr M; Cunningham P; Badman S; Kelly-Hanku A, 2023, 'ACTUP-PNG – a model for scaling up point-of-care HIV Viral Load and Early Infant Diagnosis in Papua New Guinea and other resource limited settings', in ACTUP-PNG – a model for scaling up point-of-care HIV Viral Load and Early Infant Diagnosis in Papua New Guinea and other resource limited settings, Brisbane, presented at International AIDS Society (IAS) Conference, Brisbane, 23 July 2023 - 26 July 2023

Boli R; Prankumar S; Gare J; Pekon S; Scott G; Silim S; Keno H; Ripa P; Gideon N; Kombati Z; Boas P; Starr M; Vali G; Vallely A; Willie B; Pomat W; Kelleher A; Cunningham P; Badman S; Kelly-Hanku A, 2023, 'Acceptability of point-of-care viral load testing for children <10 years and infant diagnosis in Papua New Guinea', in Acceptability of point-of-care viral load testing for children <10 years and infant diagnosis in Papua New Guinea, Brisbane, presented at International Workshop on HIV & Pediatrics, Brisbane

Czuba-Wojnilowicz E; Klemm V; Cortez-Jugo C; Turville S; Aggarwal A; Caruso F; Kelleher AD; Ahlenstiel CL, 2023, 'Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types', in Molecular Pharmaceutics, Vol. 20, pp. 2039 - 2052, http://dx.doi.org/10.1021/acs.molpharmaceut.2c01030

Gare J; Schulz M; Pekon S; Silim S; Keno H; Willie B; Boas P; Ripa P; Kombati Z; Pomat W; Kelleher A; Vallely A; Scott G; Obeng B; Starr M; Cunningham P; Badman S; Kelly-Hanku A, 2023, 'Faster results, better care - implementing point of care HIV testing in two sites in Papua New Guinea', in Faster results, better care - implementing point of care HIV testing in two sites in Papua New Guinea, Sydney, presented at 1st Australasian Conference on Point Of Care Testing for Infectious Diseases (POC23), Sydney

Gavagna G; Mahler S; Turville S; Kelleher A; Nair H, 2022, 'ANTI-SARS-COV-2 HYPERIMMUNE GLOBULIN FROM CONVALESCENT PLASMA: ACTIVITY & POTENTIAL APPLICATIONS', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 25 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862654200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hu H; Carr A; Deenick E; Phan TT; Kelleher A; Tong W; Moore J; Evans L; Toong C; Murad A; Kane A, 2022, 'PATIENT PERCEPTIONS OF HEALTH-RELATED QUALITY OF LIFE IN AN AUSTRALIAN ADULT PRIMARY IMMUNODEFICIENCY COHORT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862654200072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ahlenstiel C; Klemm V; Ledger S; Allison C; Symonds G; Pellegrini M; Kelleher A, 2021, 'RNA-directed gene therapy protects CD4+T cells during HIV challenge and delays virus rebound post-ART in humanized mice', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 24, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713652900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Klemm V; Czuba-Wojnilowicz EI; Cortez-Jugo C; Turville SG; Caruso F; Kelleher AD; Ahlenstiel CL, 2020, 'Delivering Epigenetic Silencing Sirna to the Nucleus of Hiv-1 Infected Primary Activated Cd4+T-Cells via Nanoparticle System', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, Vol. 28, pp. 468 - 469, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530089302176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, 'Clearance of HPV anal premalignant lesions and modulation of systemic immune responses to HPV oncogenes with low dose pomalidomide', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWITZERLAND, Geneva, Vol. 30, presented at Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), SWITZERLAND, Geneva, 11 December 2019 - 14 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000506799900104&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sasson SC; Cheung VTF; Gupta T; Zaunders JJ; Nahar K; Munier CM-L; Olsson-Brown A; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Long GV; Menzies AM; Kelleher A; Payne M; Fairfax B; Middleton MR; Klenerman P; Brain O, 2019, 'Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, Vol. 30, pp. 530 - 530, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 27 September 2019 - 01 October 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sasson SC; Zaunders J; Nahar K; Munier C; Read SA; Ahlensteil G; Palendira U; Scolyer RA; Carlino M; Long GV; Menzies AM; Kelleher AD, 2019, 'Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis', in European Journal of Cancer, Elsevier, Vol. 110, pp. s21 - s22, http://dx.doi.org/10.1016/j.ejca.2019.01.072

Wong A; Aggarwal A; Atthi O; Hao B; Macrae H; Churchill M; Kelleher A; Turville S, 2018, 'Modular gene therapy vectors for gene therapy cure in resting immune cells', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 4 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440002700009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bavinton B; Grinsztejn B; Phanuphak N; Jin F; Zablotska I; Prestage G; Kelleher A; Pinto A; Cooper D; Grulich A, 2017, 'HIV treatment prevents HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Y; Bailey M; Phetsouphanh C; Harvey R; Turville S; Aggarwal A; Wong A; Suzuki K; Graff-Dubois S; Autran B; Moris A; Munier ML; Koelsch K; Kent S; Zaunders J; Kelleher A, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman R; Grulich A; Kelleher A; Carr A, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400486&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Munier CML; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; van Bockel D; Suzuki K; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD, 2016, 'The primary immune response to vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T cell phenotype', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 676 - 677, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016

Sasson SC; McGill K; Weinholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168

Danta M; Zaunders J; Bailey MR; Marks K; Seddiki N; Emery S; Murray JM; Cooper DA; Koelsch K; Kelleher AD, 2012, 'Primary HIV-1 infection (PHI) is associated with reduced CD4 cell counts in terminal ileum biopsies, but not other gut biopsy sites', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 27, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fazekas de St Groth B; Seddiki N; Tan S; Higgins C; Power C; Santner-Nanan B; Nanan R; Sasson S; Zaunders J; Kelleher A; Landay A, 2005, 'Regulatory T cells and the maintenance of tolerance', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, AUSTRALIA, Melbourne, Vol. 66, pp. 412 - 412, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, AUSTRALIA, Melbourne, 29 November 2005 - 02 December 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Grulich A; Bavinton B; Stoove M; Wright E; Treloar C; Cogle A; O'Donnell D; Doyle M; Firzgerald L; Goodbun R; Holas N; Holt M; Keen P; Kelleher A; Lewin S; Lobo R; McGregor S; McMahon J; Monaghan R; Moss P; Ong J; Parkhill N; Paynter H; Power J; Russell D; Ruth S; Gray R, 2021, Agenda 2025 Ending HIV Transmission in Australia: Technical paper on science, trends and targets June 2021, Sydney, http://dx.doi.org/10.26190/unsworks/28071, https://www.afao.org.au/wp-content/uploads/2021/06/Agenda-25-Technical-Paper.pdf

Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, Reply to "issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the maraviroc switch collaborative study", http://dx.doi.org/10.1128/JCM.02207-13

van Bockel D; Kelleher A, 2005, Immune Response to HIV

Cunningham P; Kelleher AD, 2001, Monitoring resistance to antiretroviral treatments for HIV infection, 17

Patents

Kelleher A; Ahlenstiel C; Symonds G; Suzuki K, 2020, Gene therapeutic for the treatment of HIV and uses thereof, Patent No. Germany, Spain, France, United Kingdom, Italy patent no. 3294895, https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180321&CC=EP&NR=3294895A1&KC=A1

Kelleher A; Symonds G; Suzuki K, 2019, Methods for discriminating between HIV-1 and lentiviral vectors, Patent No. US patent no.10240214; Switzerland, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, Netherlands, Sweden patent no. 3283658; US 2021 pat no. 11008630, http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10240214.PN.&OS=PN/10240214&RS=PN/10240214

Preprints

Akerman A; Milogiannakis V; Jean T; Esneu C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster C; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren KJ; Bull RA; Lloyd AR; Triccas J; Tangye SG; Bartlett NW; Darley DR; Matthews G; Starck D; Rawlinson W; Brilot F; Cunningham AL; Kelleher A; Aggarwal A; Turville S, 2022, Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level, http://dx.doi.org/10.2139/ssrn.4295993

Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.21203/rs.3.rs-1207364/v1

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson S; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer D; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses, http://dx.doi.org/10.2139/ssrn.3920641

Langevin J; Featherstone LA; Di Giallonardo F; Horsburgh BA; Lloyd A; Rawlinson W; Bull RA; Kelleher A; Coin LJM; group THDMW, A distributed, privacy-preserving platform for linkage of epidemiological data with pathogen genome sequences, http://dx.doi.org/10.64898/2026.01.18.26344367

Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in mice, http://dx.doi.org/10.1101/2020.12.10.419044

Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker G; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck H-M; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, http://dx.doi.org/10.1101/2022.10.19.512954

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; More AMV; Hunt S; Douglas M; Caterson I; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level, http://dx.doi.org/10.1101/2022.12.06.22283000

Keno H; Silim S; Nano G; Boas P; Ripa P; Badman SG; Nguyen QD; Shih ST; Gare J; Pekon S; Porau W; Schulz M; Vallely AJ; Kelleher A; Kelly-Hanku A; Gray RT, Evaluating Impact of Scaling-Up Point-of-Care HIV Viral Load Testing on the HIV Epidemic and Drug Resistance in Papua New Guinea, http://dx.doi.org/10.2139/ssrn.4654898

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells, http://dx.doi.org/10.1101/2022.07.22.22277947

Phetsouphanh C; Darley D; Wilson DB; Howe A; Munier CML; Patel SK; Juno JA; Burrell LM; Kent SJ; Dore GJ; Kelleher AD; Matthews GV, Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection, http://dx.doi.org/10.1101/2021.06.01.21257759

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJ; Wilson DB; Manandhar B; Klemm V; Tan H-X; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection, http://dx.doi.org/10.1101/2023.08.27.23294704

Darley ; Dore G; Byrne A; Plit M; Brew B; Kelleher A; Matthews G, Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort, http://dx.doi.org/10.1101/2021.03.29.21254211

Foster CSP; Walker GJ; Jean T; Wong M; Brassil L; Isaacs SR; Lyu Y; Turville S; Kelleher A; Rawlinson WD, Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution, http://dx.doi.org/10.1101/2023.11.02.565396

Nyein PP; Haskelberg H; Martinello M; Lowe M; Goodman-Meza D; Avihingsanon A; Kelleher AD; Rodgers A; Schutte AE; Nnakelu EC; Byakwaga H; Trevillyan J; Losso M; Kumarasamy N; Azwa RISR; Kaplan R; Clifton B; Arnott C; Dharan NJ; Petoumenos K; Matthews GV, Optimizing Metabolic Management on Integrase-based ART (OPTIMAR): study protocol for a 2x2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk, http://dx.doi.org/10.21203/rs.3.rs-7648678/v1

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Pires AS; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study, http://dx.doi.org/10.1101/2022.06.07.22276020

Rouet R; Mazigi O; Walker GJ; Langley DB; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry JY; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull RA; Turville S; Stewart AG; Goodnow CC; Rawlinson WD; Christ D, Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies, http://dx.doi.org/10.1101/2020.12.14.422791

Aggarwal A; Stella A; Akerman A; Walker G; Milogiannakis V; McAllery S; Esneau C; Silva MR; Lu Y; Forster C; Hal SV; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Darley D; Matthews G; Starck D; Robosa R; Bartlett N; Rawlinson W; Kelleher A; Turville S, Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants, http://dx.doi.org/10.21203/rs.3.rs-1210846/v1

Walker GJ; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD, SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays, http://dx.doi.org/10.1101/2020.12.07.20245696

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffman M; Pöhlmann S; Dwyer DE; Rockett R; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants, http://dx.doi.org/10.1101/2020.12.19.20248567

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Coppola G; Yeang M; Jean T; Foster C; Hoppe AC; Munier CML; Darley D; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher AD; Turville S, SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.1101/2022.07.07.22277128

Young C; Singh M; Jackson KJ; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, Self-reactive B cells traverse a perfect storm of somatic mutagenesis to cause a virus-induced autoimmune disease, http://dx.doi.org/10.1101/2024.01.07.574561

Cronin S; Simpson J; Casanova AP; Li Y; Marín-Rojas J; van Dijk FW; Fisher K; Vahlas Z; O’Neil T; Bertram K; Lee E; Turk G; Quiroga F; Kelleher A; Vèrollet C; Balboa L; Palmer S; Duette G, The tuberculosis-associated microenvironment promotes HIV-1 persistence by impairing CD8+ T cell-mediated viral control, http://dx.doi.org/10.1101/2025.10.14.682453

Back to profile page